Otros aspectos de la cirugía bariátrica: Esteatosis hepática, metabolismo de ferritina y colesterol

Translated title of the contribution: Other aspects of bariatric surgery: Liver steatosis, ferritin and cholesterol metabolism

A. E. Pontiroli, A. Benetti, L. Folini, C. Merlotti, F. Frigè

Research output: Contribution to journalArticle

Abstract

Bariatric surgery developed in the late 1970 to treat severe hyperlipidemias in overweight individuals, not necessarily obese. Several techniques have been developed, and the concept has come first of a surgery for morbid obesity, then of a cure for diabetes in morbid obesity. There are other aspects of bariatric surgery that deserve attention, beyond BMI and diabetes, such as hypertension, poor life expectancy, increased prevalence of cancer, congestive heart failure, social inadequacy. The aim of this presentation is to review some recent development in clinical research, in the fields of liver steatosis, ferritin metabolism, and cholesterol metabolism. Liver steatosis, also called fatty liver encompasses a graduation of diseases with different clinical relevance and prognosis. NAFLD correlates with atherosclerosis, insulin resistance and diabetes mellitus. There is now evidence that weight loss, obtained through diet or restrictive surgery, reduces the prevalence (and the severity) of NAFLD. An other issue is represented by serum ferritin concentrations, that are strongly associated with fibrosis, portal and lobular inflammation in NAFLD patients, especially in the presence of obesity. Body iron contributes to excess oxidative stress already at non iron overload concentrations. Moreover, serum ferritin is an important and independent predictor of the development of diabetes. Weight loss is accompanied by reduction of ferritin, more after restrictive than malabsorptive surgery. Metabolic changes are greater after malabsorptive or mixed surgery than after purely restrictive surgery, and this has been ascribed to a greater weight loss. Studies comparing the two kinds of surgery indicate that, for the same amount of weight loss, decrease of cholesterol is greater with the former than with the latter techniques, and this difference is mainly due to a greater reduction of intestinal absorption of cholesterol. In the choice of surgery for the single patient, among other aspects, malabsorptive surgery seems to be more indicated in subjects with hyperlipidemia, especially with high cholesterol levels.

Original languageSpanish
Pages (from-to)104-108
Number of pages5
JournalNutricion Hospitalaria
Volume28
Issue numberSUPPL2
DOIs
Publication statusPublished - 2013

Fingerprint

Bariatric Surgery
Fatty Liver
Ferritins
Cholesterol
Weight Loss
Morbid Obesity
Hyperlipidemias
Iron Overload
Intestinal Absorption
Life Expectancy
Hypercholesterolemia
Serum
Insulin Resistance
Atherosclerosis
Diabetes Mellitus
Oxidative Stress
Fibrosis
Iron
Heart Failure
Obesity

Keywords

  • Bariatric surgery
  • Cholesterol metabolism
  • Ferritin
  • Liver steatosis

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Otros aspectos de la cirugía bariátrica : Esteatosis hepática, metabolismo de ferritina y colesterol. / Pontiroli, A. E.; Benetti, A.; Folini, L.; Merlotti, C.; Frigè, F.

In: Nutricion Hospitalaria, Vol. 28, No. SUPPL2, 2013, p. 104-108.

Research output: Contribution to journalArticle

Pontiroli, A. E. ; Benetti, A. ; Folini, L. ; Merlotti, C. ; Frigè, F. / Otros aspectos de la cirugía bariátrica : Esteatosis hepática, metabolismo de ferritina y colesterol. In: Nutricion Hospitalaria. 2013 ; Vol. 28, No. SUPPL2. pp. 104-108.
@article{9a2deba546f64e10a5e4f5e0b9a2c48a,
title = "Otros aspectos de la cirug{\'i}a bari{\'a}trica: Esteatosis hep{\'a}tica, metabolismo de ferritina y colesterol",
abstract = "Bariatric surgery developed in the late 1970 to treat severe hyperlipidemias in overweight individuals, not necessarily obese. Several techniques have been developed, and the concept has come first of a surgery for morbid obesity, then of a cure for diabetes in morbid obesity. There are other aspects of bariatric surgery that deserve attention, beyond BMI and diabetes, such as hypertension, poor life expectancy, increased prevalence of cancer, congestive heart failure, social inadequacy. The aim of this presentation is to review some recent development in clinical research, in the fields of liver steatosis, ferritin metabolism, and cholesterol metabolism. Liver steatosis, also called fatty liver encompasses a graduation of diseases with different clinical relevance and prognosis. NAFLD correlates with atherosclerosis, insulin resistance and diabetes mellitus. There is now evidence that weight loss, obtained through diet or restrictive surgery, reduces the prevalence (and the severity) of NAFLD. An other issue is represented by serum ferritin concentrations, that are strongly associated with fibrosis, portal and lobular inflammation in NAFLD patients, especially in the presence of obesity. Body iron contributes to excess oxidative stress already at non iron overload concentrations. Moreover, serum ferritin is an important and independent predictor of the development of diabetes. Weight loss is accompanied by reduction of ferritin, more after restrictive than malabsorptive surgery. Metabolic changes are greater after malabsorptive or mixed surgery than after purely restrictive surgery, and this has been ascribed to a greater weight loss. Studies comparing the two kinds of surgery indicate that, for the same amount of weight loss, decrease of cholesterol is greater with the former than with the latter techniques, and this difference is mainly due to a greater reduction of intestinal absorption of cholesterol. In the choice of surgery for the single patient, among other aspects, malabsorptive surgery seems to be more indicated in subjects with hyperlipidemia, especially with high cholesterol levels.",
keywords = "Bariatric surgery, Cholesterol metabolism, Ferritin, Liver steatosis",
author = "Pontiroli, {A. E.} and A. Benetti and L. Folini and C. Merlotti and F. Frig{\`e}",
year = "2013",
doi = "10.3305/nh.2013.28.sup2.6568",
language = "Spagnolo",
volume = "28",
pages = "104--108",
journal = "Nutricion Hospitalaria",
issn = "0212-1611",
publisher = "Grupo Aula Medica S.A.",
number = "SUPPL2",

}

TY - JOUR

T1 - Otros aspectos de la cirugía bariátrica

T2 - Esteatosis hepática, metabolismo de ferritina y colesterol

AU - Pontiroli, A. E.

AU - Benetti, A.

AU - Folini, L.

AU - Merlotti, C.

AU - Frigè, F.

PY - 2013

Y1 - 2013

N2 - Bariatric surgery developed in the late 1970 to treat severe hyperlipidemias in overweight individuals, not necessarily obese. Several techniques have been developed, and the concept has come first of a surgery for morbid obesity, then of a cure for diabetes in morbid obesity. There are other aspects of bariatric surgery that deserve attention, beyond BMI and diabetes, such as hypertension, poor life expectancy, increased prevalence of cancer, congestive heart failure, social inadequacy. The aim of this presentation is to review some recent development in clinical research, in the fields of liver steatosis, ferritin metabolism, and cholesterol metabolism. Liver steatosis, also called fatty liver encompasses a graduation of diseases with different clinical relevance and prognosis. NAFLD correlates with atherosclerosis, insulin resistance and diabetes mellitus. There is now evidence that weight loss, obtained through diet or restrictive surgery, reduces the prevalence (and the severity) of NAFLD. An other issue is represented by serum ferritin concentrations, that are strongly associated with fibrosis, portal and lobular inflammation in NAFLD patients, especially in the presence of obesity. Body iron contributes to excess oxidative stress already at non iron overload concentrations. Moreover, serum ferritin is an important and independent predictor of the development of diabetes. Weight loss is accompanied by reduction of ferritin, more after restrictive than malabsorptive surgery. Metabolic changes are greater after malabsorptive or mixed surgery than after purely restrictive surgery, and this has been ascribed to a greater weight loss. Studies comparing the two kinds of surgery indicate that, for the same amount of weight loss, decrease of cholesterol is greater with the former than with the latter techniques, and this difference is mainly due to a greater reduction of intestinal absorption of cholesterol. In the choice of surgery for the single patient, among other aspects, malabsorptive surgery seems to be more indicated in subjects with hyperlipidemia, especially with high cholesterol levels.

AB - Bariatric surgery developed in the late 1970 to treat severe hyperlipidemias in overweight individuals, not necessarily obese. Several techniques have been developed, and the concept has come first of a surgery for morbid obesity, then of a cure for diabetes in morbid obesity. There are other aspects of bariatric surgery that deserve attention, beyond BMI and diabetes, such as hypertension, poor life expectancy, increased prevalence of cancer, congestive heart failure, social inadequacy. The aim of this presentation is to review some recent development in clinical research, in the fields of liver steatosis, ferritin metabolism, and cholesterol metabolism. Liver steatosis, also called fatty liver encompasses a graduation of diseases with different clinical relevance and prognosis. NAFLD correlates with atherosclerosis, insulin resistance and diabetes mellitus. There is now evidence that weight loss, obtained through diet or restrictive surgery, reduces the prevalence (and the severity) of NAFLD. An other issue is represented by serum ferritin concentrations, that are strongly associated with fibrosis, portal and lobular inflammation in NAFLD patients, especially in the presence of obesity. Body iron contributes to excess oxidative stress already at non iron overload concentrations. Moreover, serum ferritin is an important and independent predictor of the development of diabetes. Weight loss is accompanied by reduction of ferritin, more after restrictive than malabsorptive surgery. Metabolic changes are greater after malabsorptive or mixed surgery than after purely restrictive surgery, and this has been ascribed to a greater weight loss. Studies comparing the two kinds of surgery indicate that, for the same amount of weight loss, decrease of cholesterol is greater with the former than with the latter techniques, and this difference is mainly due to a greater reduction of intestinal absorption of cholesterol. In the choice of surgery for the single patient, among other aspects, malabsorptive surgery seems to be more indicated in subjects with hyperlipidemia, especially with high cholesterol levels.

KW - Bariatric surgery

KW - Cholesterol metabolism

KW - Ferritin

KW - Liver steatosis

UR - http://www.scopus.com/inward/record.url?scp=84876446322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876446322&partnerID=8YFLogxK

U2 - 10.3305/nh.2013.28.sup2.6568

DO - 10.3305/nh.2013.28.sup2.6568

M3 - Articolo

C2 - 23834053

AN - SCOPUS:84876446322

VL - 28

SP - 104

EP - 108

JO - Nutricion Hospitalaria

JF - Nutricion Hospitalaria

SN - 0212-1611

IS - SUPPL2

ER -